Difference between revisions of "Hargreaves Iain P"
From Bioblast
| Line 3: | Line 3: | ||
|firstname=Iain P | |firstname=Iain P | ||
|title=Dr. | |title=Dr. | ||
|institution= | |institution=Neurometabolic Unit, | ||
The National Hospital for Neurology & Neurosurgery, UK | |||
|address=33 Queen Square | |address=33 Queen Square | ||
|area code=WC1N 3BG | |area code=WC1N 3BG | ||
Revision as of 16:23, 10 December 2018
| Name | Hargreaves Iain P, Dr. |
|---|---|
| Institution | Neurometabolic Unit,
The National Hospital for Neurology & Neurosurgery, UK |
| Address | 33 Queen Square, WC1N 3BG |
| City | London |
| State/Province | |
| Country | United Kingdom |
| i.hargreaves@ucl.ac.uk | |
| Weblink | |
| O2k-Network Lab | UK London Land JM |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Turton 2022 Int J Mol Sci | 2022 | Turton N, Cufflin N, Dewsbury M, Fitzpatrick O, Islam R, Watler LL, McPartland C, Whitelaw S, Connor C, Morris C, Fang J, Gartland O, Holt L, Hargreaves IP (2022) The biochemical assessment of mitochondrial respiratory chain disorders. Int J Mol Sci 23:7487. https://doi.org/10.3390/ijms23137487 |
| Turton 2021 Expert Opinion Orphan Drugs | 2021 | Turton N, Bowers N, Khajeh S, Hargreaves IP, Heaton RA (2021) Coenzyme Q10 and the exclusive club of diseases that show a limited response to treatment. Expert Opinion on Orphan Drugs 9:151-60. https://doi.org/10.1080/21678707.2021.1932459. |
| Mantle 2021 Antioxidants (Basel) | 2021 | Mantle D, Heaton RA, Hargreaves IP (2021) Coenzyme Q10, ageing and the nervous system: an overview. Antioxidants (Basel) 11:2. https://doi.org/10.3390/antiox11010002 |
| BEC 2020.1 doi10.26124bec2020-0001.v1 | 2020 | Gnaiger E et al ― MitoEAGLE Task Group (2020) Mitochondrial physiology. Bioenerg Commun 2020.1. https://doi.org/10.26124/bec:2020-0001.v1 |
| Hargreaves 2016 Drug Saf | 2016 | Hargreaves IP, Al Shahrani M, Wainwright L, Heales SJR (2016) Drug-induced mitochondrial toxicity. Drug Saf 39:661–74. https://doi.org/10.1007/s40264-016-0417-x. |
